2024-11-20 X Financial HaiPress
SHENZHEN,China,Nov. 19,2024 -- X Financial (NYSE: XYF) (the "Company"),a leading online personal finance company in China,today announced that it will release its unaudited financial results for the third quarter ended September 30,2024,before the open of U.S. markets on Wednesday,November 27,2024.
X Financial's management team will host an earnings conference call at 7:00 AM U.S. Eastern Time on Wednesday,2024 (8:00 PM Beijing / Hong Kong Time on the same day).
Dial-in details for the earnings conference call are as follows:
United States:
1-888-346-8982
Hong Kong:
852-301-84992
Mainland China:
4001-201203
International:
1-412-902-4272
Passcode:
X Financial
Please dial in ten minutes before the call is scheduled to begin and provide the passcode to join the call.
A replay of the conference call may be accessed by phone at the following numbers until December 4,2024:
United States:
1-877-344-7529
International:
1-412-317-0088
Passcode:
3088426
Additionally,a live and archived webcast of the conference call will be available at https://ir.xiaoyinggroup.com.
About X Financial
X Financial is a leading online personal finance company in China. The Company is committed to connecting borrowers on its platform with its institutional funding partners. With its proprietary big data-driven technology,the Company has established strategic partnerships with financial institutions across multiple areas of its business operations,enabling it to facilitate loans to prime borrowers under a robust risk assessment and control system.
For more information,please visit: https://ir.xiaoyinggroup.com.
For more information,please contact:
X Financial
Mr. Frank Fuya Zheng
E-mail: ir@xiaoying.com
Christensen
In China
Mr. Rene Vanguestaine
Phone: +86-178-1749 0483
E-mail: rene.vanguestaine@christensencomms.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map